Ch
Non vérifié

Chiesi Group

Ce que nous écrivons

BiotechnologieIndustrie pharmaceutiqueSantéSanté PubliqueScience
15/09/2026
Biotechnologie
Santé
Science
Industrie pharmaceutique
Marché du travail
Chiesi nomina David Khougazian Chief Executive Officer del Gruppo per guidare la prossima fase di crescita sostenuta dall’innovazione
1.00
15/09/2026
Biotechnologie
Santé
Science
Industrie pharmaceutique
Marché du travail
Chiesi Appoints David Khougazian as Group Chief Executive Officer to Lead the Next Phase of Innovation-Driven Growth
1.00
03/09/2026
Industrie
Biotechnologie
Industrie pharmaceutique
Écologie/Santé environnementale
Santé Publique
Santé
Chiesi Advances Its Carbon Minimal Inhaler Journey as European Submissions for Its Single Inhaler Triple Therapy (SITT) and ICS/LABA Combination Next-Generation Propellant pMDIs Are Validated
1.00

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0